14C
Showing 26 - 50 of >10,000
Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)
Completed
- Peripheral Analgesic and Anti-itch
-
Suzhou, Jiangsu, Chinaf the First Affiliated Hospital of soochow University
Apr 19, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Madison ([14C]CCX168)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
Aug 15, 2023
Asthma Trial in Ruddington (AZD4604 Inhalation Powder, 1 mg, [14C]AZD4604 Solution for Infusion 6 µg/mL (NMT 37.0 kBq/5 mL),
Not yet recruiting
- Asthma
- AZD4604 Inhalation Powder, 1 mg
- +2 more
-
Ruddington, United KingdomQuotient Sciences Limited
Nov 27, 2023
Healthy Male Subjects Trial in Shanghai ([14C] Antaitavir Hasophate)
Completed
- Healthy Male Subjects
- [14C] Antaitavir Hasophate
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Jan 4, 2023
Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)
Recruiting
- Imumune Thrombocytopenia(ITP) Human Mass Balance
- HMPL-523
- 150 µCi [14C]HMPL-523
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Mar 12, 2023
Solid Tumors Trial in Budapest ([14C] Subasumstat, Subasumstat)
Not yet recruiting
- Solid Tumors
- [14C] Subasumstat
- Subasumstat
-
Budapest, Hungary
- +1 more
Jul 28, 2023
Healthy Trial in Suzhou ([14C]Iruplinalkib (WX-0593))
Completed
- Healthy
- [14C]Iruplinalkib (WX-0593)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 5, 2023
Healthy Subjects Trial in Nanjing ([14C] IBI351)
Not yet recruiting
- Healthy Subjects
- [14C] IBI351
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Nov 15, 2022
Type II Diabetes Trial in Suzhou ([14C]HSK7653)
Completed
- Type II Diabetes
-
Suzhou, Chinathe First Affilicated Hospital of Soochow University
Dec 9, 2022
Healthy Volunteers Trial in Leeds (E7386 Tablet, (14C)E7386 Capsule, (14C)E7386)
Recruiting
- Healthy Volunteers
- E7386 Tablet
- +2 more
-
Leeds, United KingdomLabcorp Clinical Research Unit
Oct 31, 2022
Healthy Male Subjects Trial in Tokyo (TAS-303, [14C]TAS-303)
Active, not recruiting
- Healthy Male Subjects
- TAS-303, [14C]TAS-303
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Nov 17, 2022
Healthy Volunteer Trial in Suzhou ([14C]Afuresertib)
Not yet recruiting
- Healthy Volunteer
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Aug 3, 2022
Healthy Trial in Madison ([14C] Selpercatinib, Selpercatinib)
Completed
- Healthy
- [14C] Selpercatinib
- Selpercatinib
-
Madison, WisconsinLabCorp CRU, Inc.
Nov 21, 2022
Influenza, Human Trial (ZX-7101A 80mg)
Not yet recruiting
- Influenza, Human
- ZX-7101A 80mg
- (no location specified)
Feb 6, 2023
Gaucher's Disease Type I Trial (Genz-112638, [14C]-Genz-112638)
Completed
- Gaucher's Disease Type I
- (no location specified)
Nov 16, 2023
Healthy Volunteers Trial in Madison ([14C]-Fosgonimeton)
Active, not recruiting
- Healthy Volunteers
-
Madison, WisconsinLabcorp Clinical Research Unit
Aug 19, 2022
Fungal Infection Trial in Ruddington ([14C]-APX001 Oral Solution, [14C]-APX001 Solution for Infusion)
Completed
- Fungal Infection
- [14C]-APX001 Oral Solution
- [14C]-APX001 Solution for Infusion
-
Ruddington, Nottingham, United KingdomQuotient Sciences
Sep 25, 2022
Healthy Trial in Baltimore ([14C]-TNP-2092)
Completed
- Healthy
-
Baltimore, MarylandPharmaron Clinical Pharmacology Center
Oct 18, 2022
Healthy Trial in Austin ([phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471)
Recruiting
- Healthy
-
Austin, TexasPPD Phase I Clinic
Jun 29, 2023